F. Bartoli Klugmann
University of Trieste
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by F. Bartoli Klugmann.
Pharmacological Research Communications | 1981
S. Klugmann; F. Bartoli Klugmann; Giuliana Decorti; D. Gori; F. Silvestri; F. Camerini
Summary The effects of two calcium antagonistic drugs, verapamil (V) and nifedipine (N), on the experimental cardiomyopathy induced by adriamycin (ADM) in Swiss mice have been tested. The study was performed by monitoring the survival time of the animals and by evaluating the histologic cardiac changes. We have shown that the two drugs do not protect against the development of the cardiomyopathy; N moreover accentuates the cardiotoxic effect of ADM; perhaps N and ADM have synergic effects on myocardial calcium metabolism.
Cancer Letters | 1983
Giuliana Decorti; F. Bartoli Klugmann; Franco Mallardi; S. Klugmann; B. Benussi; Vittorio Grill; L. Baldini
The effect of ICRF 159 on adriamycin (ADR) cardiotoxicity and on total myocardial calcium content was examined in rats. ICRF 159 did not increase the survival time of ADR-treated animals; however the histological findings showed a significant prevention of ADR-induced cardiomyopathy (CMP) by ICRF. The total myocardial calcium content of animals treated with ADR was significantly higher, while no significant difference was seen in animals pretreated with ICRF 159 as compared with controls. As these findings suggested a role of calcium in ADR CMP and in the pharmacological action of ICRF in this disease, we also tested a closely related chelating agent, EDTA. This molecule decreased myocardial calcium levels in ADR-treated animals almost to normal values; however the histological cardiac alterations were not prevented.
Inflammation Research | 1989
Giuliana Decorti; F. Bartoli Klugmann; Luigi Candussio; L. Baldini
In the present study, we evaluated in mouse and rat mast cells if adriamycin uptake is related to histamine release. In addition, the uptake of the antineoplastic drug and histamine release were studied in other normal and neoplastic cell lines. The effect of sodium cromoglycate was also examined.Adriamycin induced histamine release from mixed or purified mast cells of the mouse and rat. This exocytotic response was quantitatively related to intracellular concentrations of adriamycin. Significant differences in adriamycin uptake were observed between mast cells and other normal and neoplastic cells. When peritoneal mast cells were treated with sodium cromoglycate, histamine release and adriamycin uptake were significantly reduced. In contrast, incubation of other cells with cromoglycate only slightly reduced the cellular concentration of the antineoplastic drug.
Pharmacological Research Communications | 1986
F. Bartoli Klugmann; Giuliana Decorti; Luigi Candussio; L. Baldini
The anticonvulsant activity of two polyethylene glycols of different molecular weight (400 and 4000) was tested in mice. The two substances were inactive in the maximal electroshock test, but, when intraperitoneally administered, were efficacious in the pentetrazole and strychnine seizure tests. Polyethylene glycol 4000 showed the most potent anticonvulsant action. On the contrary, when polyethylene glycols were orally administered, they did not alter the time for seizure onset and for death.
Pharmacological Research Communications | 1985
Aurelia Tubaro; Giuliana Decorti; C. Zilli; F. Bartoli Klugmann; R. Della Loggia; Franco Mallardi; Vittorio Grill
The neurotoxic effects of a single intraperitoneal or intravenous injection of doxorubicin were evaluated in CD1 mice by means of the rotarod test. The test was performed daily for nine weeks after treatment. For both routes of administration, animals were treated with various doxorubicin dosages ranging from 18 to 5.9 mg/kg. The three higher i.v. doses (18, 14.4 and 12.5 mg/kg) of doxorubicin induced a severe motor coordination impairment. The histopathological analysis of these animals showed severe damage of sensory nerves. On the contrary, all the i.p. treated animals did not show any sign of motor impairment and of appreciable neurohistological lesion.
Inflammation Research | 1988
Luigi Candussio; F. Bartoli Klugmann; Giuliana Decorti; L. Baldini
The antineoplastic drug adriamycin, at a concentration of 100 μg/ml, caused a significant histamine release from rat peritoneal mast cells. This exocytotic process was unaffected by pretreatment with various concentrations of catalase, superoxide-dismutase,d-mannitol, alpha-tocopherol and reduced glutathione. Only very high concentrations of n-acetylcysteine significantly limited this release; this substance was also active in limiting histamine secretion induced by a classic mast cell secretagogue, compound 48/80.
Pharmacological Research Communications | 1977
F. Bartoli Klugmann; B. Pani; G. Castellani
Summary The effect of two Platinum (II), two Rhodium (I), and two Ruthenium (II) complexes on the in vitro blastogenic response of human peripheral lymphocytes has been tested. All compounds except Ru(II) (DMSO) 2 o -phen-Cl 2 strongly inhibit the blastogenic response stimulated by mixed culture and by PHA. In the discussion of the results special emphasis is given to the pronounced difference between inhibition of PHA- and mixed culture-stimulated lymphocytes shown by the two platinum compounds.
Pharmacological Research | 1990
Enrico Crivellato; F. Bartoli Klugmann; Giuliana Decorti; Luigi Candussio; Franco Mallardi; L. Baldini
Pharmacological Research | 1995
Luigi Candussio; Giuliana Decorti; L. Baldini; F. Bartoli Klugmann
Pharmacological Research | 1995
Giuliana Decorti; Luigi Candussio; L. Baldini; F. Bartoli Klugmann